A comparative evaluation of various invasion assays testing colon carcinoma cell lines

Por Both, N J de, Vermey, M, Dinjens, W N, Bosman, F T
Publicado em 1999

The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis

Por Koppert, L B, Schutte, M, Abbou, M, Tilanus, H W, Dinjens, W N M
Publicado em 2004

E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus

Por Wijnhoven, B P L, Both, N J de, Dekken, H van, Tilanus, H W, Dinjens, W N M
Publicado em 1999

Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells.

Por de Bruïne, A. P., Dinjens, W. N., van der Linden, E. P., Pijls, M. M., Moerkerk, P. T., Bosman, F. T.
Publicado em 1993

Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116

Por Wijnhoven, B P L, Tilanus, M G J, Morris, A G, Darnton, S J, Tilanus, H W, Dinjens, W N M
Publicado em 2000

Allelotype of 28 human breast cancer cell lines and xenografts

Por Harkes, I C, Elstrodt, F, Dinjens, W N M, Molier, M, Klijn, J G M, Berns, E M J J, Schutte, M
Publicado em 2003

In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells.

Por de Vries, J. E., Dinjens, W. N., De Bruyne, G. K., Verspaget, H. W., van der Linden, E. P., de Bruïne, A. P., Mareel, M. M., Bosman, F. T., ten Kate, J.
Publicado em 1995

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression

Por Koppert, L B, van der Velden, A W, van de Wetering, M, Abbou, M, van den Ouweland, A M W, Tilanus, H W, Wijnhoven, B P L, Dinjens, W N M
Publicado em 2004

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma

Por van Nistelrooij, A. M. J., van Marion, R., van Ijcken, W. F. J., de Klein, A., Wagner, A., Biermann, K., Spaander, M. C. W., van Lanschot, J. J. B., Dinjens, W. N. M., Wijnhoven, B. P. L.
Publicado no Fam Cancer (2017)

Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats

Por You, J-F, Buhard, O, Ligtenberg, M J L, Kets, C M, Niessen, R C, Hofstra, R M W, Wagner, A, Dinjens, W N M, Colas, C, Lascols, O, Collura, A, Flejou, J-F, Duval, A, Hamelin, R
Publicado em 2010

Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers

Por Goverde, A., Spaander, M. C. W., Nieboer, D., van den Ouweland, A. M. W., Dinjens, W. N. M., Dubbink, H. J., Tops, C. J., ten Broeke, S. W., Bruno, M. J., Hofstra, R. M. W., Steyerberg, E. W., Wagner, A.
Publicado no Fam Cancer (2017)

Quality control in diagnostic molecular pathology in the Netherlands; proficiency testing for patient identification in tissue samples

Por Thunnissen, F B J M, Tilanus, M G J, Ligtenberg, M J L, Nederlof, P M, Dinjens, W N M, Meulemans, E, Van den Brule, A J C, van Noesel, C J M, de Leeuw, W J F, Schuuring, E
Publicado em 2004

O10.05 FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND...

Por Taal, W., Oosterkamp, H.M., Walenkamp, A.M.E., Dubbink, H.J., Beerepoot, L.V., Hanse, M., Buter, J., Honkoop, A., Boerman, D., Vos, F.Y.F., Dinjens, W.N.M., Enting, R.H., Taphoorn, M.J.B., van den Berkmortel, F.W.P.J., Jansen, R., Brandsma, D., Bromberg, J.E., van Heuvel, I., Vernhout, R.M., van der Holt, B., van den Bent, M.J.
Publicado em 2014